Orrick Advises COVA Acquisition on $3.82 Billion SPAC Merger with ECARX

1 minute read | December.20.2022

Orrick is advising COVA Acquisition Corp., a special purpose acquisition company, on its definitive agreement to merge with mobility tech company ECARX Holdings. The business combination closed on December 20, 2022, upon which ECARX shares and warrants began trading on the Nasdaq under the ticker symbols ECX and ECXWW, respectively. 

Proceeds from the transaction will be used to accelerate ECARX’s technology development and the roll-out of new products, support strategic acquisitions or investments, as well as create further pathways for global growth.

The Orrick team advising COVA Acquisition is led by Albert Vanderlaan and Hari Raman and includes Jeff Zhang, Brian Blood, Travis Cherry, Sami Ghubril, Tom Sanford, Martha Wang, Shelley Zhang, Yali Hu, Yuan Tian, Peter Elias, Sarah Schaedler, Steven Malvey, Shannon Yavorsky, Asami Ono, Daniel Healow, Daniel Kearney, Matthew Coleman, Michael Wiesner, Amber Zhou, Maria Sergeyeva, Jeanine McGuinness, Milana Karayanidi, Jennifer Criss, and Matthew Rose.